PureTech Health plc (PRTC) Earnings History
Annual and quarterly earnings data from 2012 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 26.0% | -2818.9% | 1108.3% |
| 2023 | -48.1% | -4390.4% | -1972.9% |
| 2022 | -6546.2% | -9464.4% | -2409.3% |
| 2021 | -1007.0% | -1506.0% | -606.9% |
| 2020 | 100.0% | -1433.1% | 71.8% |
Download Data
Export PRTC earnings history in CSV or JSON format
Free sign-in required to download data
PureTech Health plc (PRTC) Earnings Overview
As of March 1, 2026, PureTech Health plc (PRTC) reported trailing twelve-month net income of -$31M, reflecting +1.8% year-over-year growth. The company earned $-1.31 per diluted share over the past four quarters, with a net profit margin of 11.1%.
Looking at the long-term picture, PRTC's 5-year EPS compound annual growth rate (CAGR) stands at -32.6%, signaling declining earnings. The company achieved its highest annual net income of $421M in fiscal 2019.
PureTech Health plc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including REGN ($4.50B net income, 0.3% margin), CNTA (-$243M net income), IMNM (-$223M net income, -32.4% margin), PRTC has outperformed on profitability metrics. Compare PRTC vs REGN →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $54M | +181.4% | -$136M | $2.00 | 1108.3% | -2818.9% |
| 2023 | -$66M | -30.5% | -$146M | $-2.40 | -1972.9% | -4390.4% |
| 2022 | -$50M | +16.8% | -$198M | $-1.80 | -2409.3% | -9464.4% |
| 2021 | -$61M | -1111.8% | -$150M | $-2.10 | -606.9% | -1506.0% |
| 2020 | $6M | -98.6% | -$120M | $0.20 | 71.8% | -1433.1% |
| 2019 | $421M | +1064.7% | -$135M | $14.40 | 4847.4% | -1558.5% |
| 2018 | -$44M | -241.4% | -$104M | $-1.60 | -266.7% | -635.4% |
| 2017 | $31M | +163.3% | -$115M | $1.10 | 4749.1% | -17756.9% |
| 2016 | -$49M | -23.9% | -$74M | $-2.10 | -1101.2% | -1668.4% |
| 2015 | -$39M | +5.4% | -$44M | $-2.10 | -335.5% | -371.7% |
See PRTC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRTC Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare PRTC vs AGIO
See how PRTC stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is PRTC growing earnings?
PRTC EPS of $-1.31 reflects slowing growth at +1.8%, below the 5-year CAGR of -32.6%. TTM net income is $-31M. Expansion rate has moderated.
What are PRTC's profit margins?
PureTech Health plc net margin is +11.1%, with operating margin at -28.2%. Margins sit within typical range for the sector.
How consistent are PRTC's earnings?
PRTC earnings data spans 2012-2024. The current earnings trend is +1.8% YoY. Historical data enables comparison across business cycles.